Home LiteratureArticle Details
PMID: 1313515 Published · ppublish English Journal Article

A potent and selective non-peptide antagonist of the neurokinin A (NK2) receptor.

Life sciences ·Vol. 50 ·No. 15 ·1992-00-00 ·Pages PL101-6

Emonds-Alt X, Vilain P, Goulaouic P, Proietto V, Van Broeck D, Advenier C, Naline E, Neliat G, Le Fur G, Brelière JC

Abstract

SR 48968 is a potent and selective non-peptide antagonist of the neurokinin A (NK2) receptor. SR 48968 selectively inhibited neurokinin A binding to its receptor and was a competitive antagonist of neurokinin A-mediated contraction of different isolated smooth muscle preparations from various species including human. In vivo, the compound inhibited the bronchoconstriction induced by neurokinin A in guinea pigs. SR 48968 can be used to study the physiological or pathological role of neurokinin A and may be useful in the treatment of neurokinin A-dependent pathology.

MeSH Terms
Animals Benzamides/chemistry,pharmacology Binding, Competitive Bronchoconstriction/drug effects Cricetinae Duodenum/metabolism Intestinal Mucosa/metabolism Neurokinin A/antagonists & inhibitors Piperidines Rabbits Rats Receptors, Neurokinin-2 Receptors, Neurotransmitter/drug effects Vasoconstriction/drug effects
Chemicals
Benzamides Piperidines Receptors, Neurokinin-2 Receptors, Neurotransmitter SR 48968 Neurokinin A
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Emonds-Alt X
Sanofi Recherche, Montpellier, France.
Vilain P
Goulaouic P
Proietto V
Van Broeck D
Advenier C
Naline E
Neliat G
Le Fur G
Brelière J C
Article Info
Journal
Life sciences
Abbr.
Life Sci
ISSN
0024-3205
Published
1992-00-00
Pages
PL101-6
Language
English
Region
Netherlands
NLM ID
0375521
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]